Furosemide Tablets Solicitation

SOL #: SPE2D2-26-R-0005Pre-Solicitation

Overview

Buyer

DEPT OF DEFENSE
Defense Logistics Agency
DLA TROOP SUPPORT
PHILADELPHIA, PA, 19111, United States

Place of Performance

Place of performance not available

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

Drugs And Biologicals (6505)

Set Aside

No set aside specified

Timeline

1
Posted
Mar 12, 2026
2
Last Updated
May 19, 2026
3
Response Deadline
Jun 4, 2026, 7:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Defense Logistics Agency (DLA) is soliciting offers for Furosemide Tablets in various strengths and counts to support the DLA, VA, BoP, and IHS Pharmaceutical Prime Vendor (PPV) programs. This is an UNRESTRICTED acquisition for a national supply source. The solicitation closing date has been extended to June 4, 2026, at 3:00 PM EST.

Scope of Work

This opportunity seeks to establish a reliable supply of FDA-approved, therapeutically equivalent Furosemide tablets. Key requirements include:

  • Furosemide 20 MG Tablets (90 and 1000 count bottles)
  • Furosemide 40 MG Tablets (90 and 1000 count bottles)
  • Furosemide 80 MG Tablets (500 count bottle/box) Products must have a National Drug Code (NDC), be compatible with automated dispensing units, and feature child-proof closures for unit-of-use packaging. Bar code labeling (GS1-128 or HIBCC standards) with lot number and expiration date is mandatory. Compliance with the Drug Supply Chain Security Act (DSCSA) and cGMP status for manufacturing facilities are also required.

Contract Details

  • Type of Contract: Firm-fixed-price requirements contract.
  • Period of Performance: One base year with four option years, not to exceed five years.
  • Contract Price Effective Date: No more than 60 calendar days after award.
  • Contract Performance Date: 45 calendar days after award (ready to fill orders).
  • Estimated quantities are provided in Appendix B, but actual quantities may vary.

Submission & Evaluation

  • Submission Method: Electronically via the Defense Logistics Agency Internet Bid Board System (DIBBS).
  • Submission Deadline: June 4, 2026, 3:00 PM EST.
  • Evaluation Criteria: Lowest Price Technically Acceptable (LPTA).
  • Proposals will be evaluated on Technical Requirements, Past Performance, and Price (lowest evaluated aggregate price).
  • Offerors must provide pricing for all line items for the base and option years. Discussions may be held to clarify proposals.

Eligibility / Set-Aside

  • Set-Aside: UNRESTRICTED.
  • NAICS Code: 325412 (Pharmaceutical Preparation Manufacturing).
  • Size Standard: 1,300 employees.
  • Large businesses must submit a subcontracting plan.

Additional Notes

Offerors may engage with PPV contractors regarding business-to-business agreements prior to submission. The Government reserves the right to modify ordering sites/activities. The price paid by the Government to a PPV contractor may be adjusted by distribution fees.

People

Points of Contact

Jason C. WraySECONDARY

Files

Files

Download
Download

Versions

Version 3Viewing
Pre-Solicitation
Posted: May 19, 2026
Version 2
Pre-Solicitation
Posted: Apr 21, 2026
View
Version 1
Pre-Solicitation
Posted: Mar 12, 2026
View
Furosemide Tablets Solicitation | GovScope